New drug combo targets Hard-to-Treat cancers in early trial
Disease control
Not yet recruiting
This study tests an experimental drug called BSI-082 in adults with advanced or spreading solid tumors that have not responded to standard treatments. In the first part, patients receive BSI-082 alone at increasing doses. In the second part, they receive BSI-082 plus another drug…
Phase: PHASE1 • Sponsor: Lei Zheng • Aim: Disease control
Last updated May 15, 2026 11:54 UTC